General Consultation Period: 01/10/13 – 01/11/13
Background
ICIS is implementing a process of rolling consultation on all of its pricing methodologies. Consultation paper GMC011/13 is part of this formal process and covers all of the ICIS primary price points included in the Paraxylene weekly publications.
The consultation asked both general questions about the suitability of the ICIS pricing methodology and questions addressing specific paraxylene market issues.
Click here to download the Paraxylene Methodology Consultation
ICIS Decision
There were no formal responses to consultation GMC 11/13. ICIS will not be proposing any immediate changes to the methodology of the Paraxylene Report. Any decision to change this methodology will be communicated to subscribers using the usual channels and with the usual notice period.
ICIS continues to welcome any feedback on its Paraxylene methodology outside of the formal consultation process.
To provide further comments or feedback please contact Barbara Ortner, Head of Market Reporting:
